RecruitingNCT05204108

Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography

Evaluation of the Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography: a Prospective Study


Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Enrollment

1,000 participants

Start Date

Apr 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the diagnostic accuracy of CEUS for the preoperative staging of bladder cancer, which would benefit the implementation of efficient therapeutic strategies.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a special ultrasound technique using contrast dye (contrast-enhanced ultrasound, or CEUS) can accurately determine whether bladder cancer has grown into the muscle — which is critical for deciding the right treatment. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis of primary bladder cancer - You have not yet received any surgery, chemotherapy, immunotherapy, or other treatment for this bladder cancer **You may NOT be eligible if...** - Your diagnosis of bladder cancer has been ruled out - You have had prior bladder surgery, pelvic treatment, or any therapy for bladder cancer - Your bladder cancer is a recurrence (not a new first diagnosis) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05204108


Related Trials